These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1917157)

  • 1. Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues.
    Reed MJ; Aherne GW; Ghilchik MW; Patel S; Chakraborty J
    Int J Cancer; 1991 Oct; 49(4):562-5. PubMed ID: 1917157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione.
    Reed MJ; Owen AM; Lai LC; Coldham NG; Ghilchik MW; Shaikh NA; James VH
    Int J Cancer; 1989 Aug; 44(2):233-7. PubMed ID: 2759729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer.
    Reed MJ; Lai LC; Owen AM; Singh A; Coldham NG; Purohit A; Ghilchik MW; Shaikh NA; James VH
    Cancer Res; 1990 Jan; 50(1):193-6. PubMed ID: 2293555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of oestrogen synthesis in postmenopausal women with breast cancer.
    James VH; Reed MJ; Purohit A
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):149-53. PubMed ID: 1525057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase and other inhibitors in breast and prostatic cancer.
    Brodie AM; Banks PK; Inkster SE; Son C; Koos RD
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1043-8. PubMed ID: 2285580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aromatase in breast tumors.
    Reed MJ
    Breast Cancer Res Treat; 1994; 30(1):7-17. PubMed ID: 7949206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
    Goss PE; Powles TJ; Dowsett M; Hutchison G; Brodie AM; Gazet JC; Coombes RC
    Cancer Res; 1986 Sep; 46(9):4823-6. PubMed ID: 2942241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.
    Davies JH; Dowsett M; Jacobs S; Coombes RC; Hedley A; Shearer RJ
    Br J Cancer; 1992 Jul; 66(1):139-42. PubMed ID: 1637664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects.
    Geisler J; Johannessen DC; Anker G; Lønning PE
    Eur J Cancer; 1996 May; 32A(5):789-92. PubMed ID: 9081355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
    MacNeill FA; Jacobs S; Lønning PE; Powles TJ; Dowsett M
    Br J Cancer; 1994 Jun; 69(6):1171-5. PubMed ID: 8198987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours.
    Purohit A; Lai LC; Singh A; Coldham NG; Ghilchik MW; Reed MJ; James VH
    J Steroid Biochem; 1989; 34(1-6):443-6. PubMed ID: 2533950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.
    Dowsett M; Goss PE; Powles TJ; Hutchinson G; Brodie AM; Jeffcoate SL; Coombes RC
    Cancer Res; 1987 Apr; 47(7):1957-61. PubMed ID: 3815384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.
    Johannessen DC; Adlercreutz H; Fotsis T; Lønning PE
    Br J Cancer; 1993 Aug; 68(2):393-8. PubMed ID: 8135918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer.
    Murray R; Pitt P
    Breast Cancer Res Treat; 1995 Sep; 35(3):249-53. PubMed ID: 7579495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors: basic and clinical studies.
    Brodie AM; Coombes RC; Dowsett M
    J Steroid Biochem; 1987; 27(4-6):899-903. PubMed ID: 3320568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer.
    Reed MJ; Christodoulides A; Koistinen R; Seppälä M; Teale JD; Ghilchik MW
    Int J Cancer; 1992 Sep; 52(2):208-12. PubMed ID: 1381703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of tissue oestradiol levels in human breast cancer.
    Santen RJ
    Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment.
    Lønning PE; Dowsett M; Jones A; Ekse D; Jacobs S; McNeil F; Johannessen DC; Powles TJ
    Breast Cancer Res Treat; 1992; 23(1-2):57-62. PubMed ID: 1446052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment with aromatase inhibitor 4-hydroxandrostenedione on the nonhuman primate menstrual cycle.
    Brodie AM; Hammond JO; Ghosh M; Meyer K; Albrecht ED
    Cancer Res; 1989 Sep; 49(17):4780-4. PubMed ID: 2758411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between plasma androstenedione, plasma oestrone and androstenedione to oestrone conversion rates in post-menopausal women with and without fractures.
    Pelc B; Marshall DH; Guha P; Khan MY; Nordin BE
    Clin Sci Mol Med; 1978 Feb; 54(2):125-31. PubMed ID: 620501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.